BI-1915

N/A

Report date: 2025/01/26 16:20:29
NME

Base Information

Drug NameBI-1915
Drug Alias Namecathepsin S inhibitor 1 (Boehringer Ingelheim)BI-1915
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsins inhibitors
TargetsCathepsins
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim International Gmbh
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A